REVIEW ON THE SIGNIFICANCE OF QUINAZOLINE DERIVATIVES AS BROAD SPECTRUM ANTI-CANCER AGENTS. | ||||
| Al-Azhar Journal of Pharmaceutical Sciences | ||||
| Article 2, Volume 64, Issue 2, September and October 2021, Page 21-40 PDF (636.64 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ajps.2021.187748 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Mohamed El-Zahabi
| ||||
| Department of Pharmaceutical Medicinal Chemistry & Drug Design, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt. | ||||
| Abstract | ||||
| Cancer is one of the major causes of human mortality worldwide. A number of approved antineoplastic medications and treatment regimens are already working in the field, and several new compounds are in different phases of clinical trials. An extensive series of anticancer drugs exist in the market, and studies explained that these molecules are associated with different types of adverse side effects. The reduction of the cytotoxicity of drugs to normal cells is a major problem in anticancer therapy. Therefore, researchers around the globe are involved in the development of more efficient and safer anticancer drugs. An interesting output of extensive research is that the quinazoline scaffold and its various derivatives can be explored further as a significant class of cancer chemotherapeutic agents that has already shown promising activities against different tumors. In general, quinazoline derivatives have already occupied a crucial place in modern medicinal chemistry. Quinazoline is one of the most studied moieties in medicinal chemistry due to the wide range of biological properties such as the anticancer, antibacterial, anti-inflammatory, antimalarial and antihypertensive activities. The anticancer activity of this scaffold has been well established. | ||||
| Keywords | ||||
| Quinazoline; cancer; Immunomodulators; thymidylate enzyme; DNA inhibition; tubulin polymerization | ||||
|
Statistics Article View: 480 PDF Download: 745 |
||||
